COMBINATION THERAPY FOR TREATING CANCER WITH AN INTRAVENOUS ADMINISTRATION OF A RECOMBINANT MVA AND AN ANTIBODY

摘要

The invention relates to a pharmaceutical combination and related methods for reducing tumor volume and/or increasing the survival of a cancer patient. The combination comprises an intravenous administration of a recombinant MVA encoding a tumor-associated antigen and an administration of an antibody to a cancer patient.